Clinical Trial

Telepsychiatry in Children: Diagnostic Evaluation of Autism Spectrum Disorder

Study acronym: TELE-TSA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder recognized as a major national cause in 2012. The French Autism Plan 2018-2022 emphasizes early diagnosis and intervention for better cognitive and behavioral outcomes. The COVID-19 pandemic complicates the use of the ADOS-2 diagnostic tool due to mask-wearing and distancing requirements. To address this, the Brief Observation Symptoms of Autism (BOSA) has been adapted for remote assessment. The BOSA, translated into French, is recommended alongside the Autism Diagnostic Interview -Revised (ADI-R) for complementary diagnostic algorithms. No similar projects have been undertaken in France or Canada.
Trial Details
NCT Number NCT06622395
Lead Sponsor Centre Hospitalier St Anne
Conditions Autism Spectrum Disorder (ASD), Neurodevelopmental Disorders
Enrollment 137 participants
Start Date 2022-04-29
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-02